39824 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 12
00:09 UTC
|
SEDG
SolarEdge Technologies
|
◎ Target | Maheep Mandloi ★★☆☆☆ #2656 | Neutral | $38.00→ $40.00+5.3% |
|
Sep 12
00:09 UTC
|
SEDG
SolarEdge Technologies
|
◎ Target | David Arcaro ★★☆☆☆ #2628 | Equal Weight | $35.00→ $33.00-5.7% |
|
Sep 12
00:09 UTC
|
SEDG
SolarEdge Technologies
|
◎ Target | Christopher Dendrinos not yet tracked | Sec→ r Perform | $24.00→ $30.00+25.0% |
|
Sep 12
00:09 UTC
|
RH
RH
|
◎ Target | Simeon Gutman ★★★★☆ #855 | Overweight | $240.00→ $210.00-12.5% |
|
Sep 12
00:09 UTC
|
RH
RH
|
◎ Target | Zachary Fadem ★★★☆☆ #1861 | Overweight | $225.00→ $175.00-22.2% |
|
Sep 12
00:09 UTC
|
RH
RH
|
◎ Target | Michael Lasser ★★★★☆ #932 | Neutral | $155.00→ $154.00-0.6% |
|
Sep 12
00:09 UTC
|
RH
RH
|
◎ Target | Cristina Fernandez ★★☆☆☆ #2501 | Market Perform | $140.00→ $155.00+10.7% |
|
Sep 12
00:09 UTC
|
RH
RH
|
◎ Target | Christopher Nardone ★★★☆☆ #1443 | Underperform | $156.00→ $114.00-26.9% |
|
Sep 12
00:09 UTC
|
RH
RH
|
◎ Target | Peter Benedict ★★★★☆ #369 | Neutral | $165.00→ $160.00-3.0% |
|
Sep 12
00:09 UTC
|
RH
RH
|
◎ Target | Christopher Horvers ★★★★☆ #710 | Overweight | $212.00→ $190.00-10.4% |
|
Sep 12
00:09 UTC
|
RH
RH
|
◎ Target | Max Rakhlenko ★★★☆☆ #1383 | Buy | $220.00→ $190.00-13.6% |
|
Sep 12
00:09 UTC
|
PPIH
Perma-Pipe International
|
◎ Target | Sergey Glinyanov ★★★★★ #231 | Buy | $29.55→ $38.00+28.6% |
|
Sep 12
00:09 UTC
|
POOL
Pool
|
◎ Target | Sam Reid ★★☆☆☆ #2801 | Equal Weight | $215.00→ $185.00-14.0% |
|
Sep 12
00:09 UTC
|
PLTR
Palantir Technologies
|
◎ Target | Gil Luria ★★★☆☆ #1122 | Buy | $200.00→ $250.00+25.0% |
|
Sep 12
00:09 UTC
|
PKG
Packaging Corporation of America
|
◎ Target | George Staphos ★★☆☆☆ #2350 | Buy | $280.00→ $260.00-7.1% |
|
Sep 12
00:09 UTC
|
PHM
PulteGroup
|
◎ Target | Sam Reid ★★☆☆☆ #2801 | Overweight | $150.00→ $145.00-3.3% |
|
Sep 12
00:09 UTC
|
PFGC
Performance Food Group
|
◎ Target | Andrew M. Charles not yet tracked | Buy | $120.00→ $115.00-4.2% |
|
Sep 12
00:09 UTC
|
PDEX
Pro-Dex
|
◎ Target | Edward Woo ★★☆☆☆ #2345 | Buy | $70.00→ $74.00+5.7% |
|
Sep 12
00:09 UTC
|
PAYX
Paychex
|
◎ Target | Bryan Bergin ★★★☆☆ #1157 | Hold | $98.00→ $117.00+19.4% |
|
Sep 12
00:09 UTC
|
OVID
Ovid Therapeutics
|
◎ Target | Raghuram Selvaraju not yet tracked | Buy | $4.00→ $5.00+25.0% |
|
Sep 12
00:09 UTC
|
ORCL
Oracle
|
◎ Target | Rishi Jaluria ★★★☆☆ #2175 | Sec→ r Perform | $190.00→ $165.00-13.2% |
|
Sep 12
00:09 UTC
|
ORCL
Oracle
|
◎ Target | Keith Bachman ★★★☆☆ #1089 | Outperform | $220.00→ $195.00-11.4% |
|
Sep 12
00:09 UTC
|
ORCL
Oracle
|
◎ Target | Karl Keirstead ★★★☆☆ #1733 | Buy | $245.00→ $250.00+2.0% |
|
Sep 12
00:09 UTC
|
ORCL
Oracle
|
◎ Target | Brad Reback ★★★☆☆ #2205 | Buy | $220.00→ $200.00-9.1% |
|
Sep 12
00:09 UTC
|
ORCL
Oracle
|
◎ Target | Raimo Lenschow ★★★☆☆ #1374 | Overweight | $250.00→ $252.00+0.8% |
|
Sep 12
00:09 UTC
|
OMDA
Omada Health
|
◎ Target | Saket Kalia ★★★☆☆ #1316 | Overweight | $25.00→ $27.00+8.0% |
|
Sep 12
00:09 UTC
|
OKE
ONEOK
|
◎ Target | Jason Gabelman ★★★☆☆ #1485 | Hold | $90.00→ $93.00+3.3% |
|
Sep 12
00:09 UTC
|
OC
Owens Corning
|
◎ Target | Sam Reid ★★☆☆☆ #2801 | Overweight | $172.00→ $150.00-12.8% |
|
Sep 12
00:09 UTC
|
NOW
ServiceNow
|
◎ Target | Mike Cikos ★★★★☆ #364 | Buy | $115.00→ $155.00+34.8% |
|
Sep 12
00:09 UTC
|
NJR
NewJersey Resources
|
◎ Target | Richard Sunderland ★★★☆☆ #1603 | Overweight | $64.00→ $63.00-1.6% |
|
Sep 12
00:09 UTC
|
NBIX
Neurocrine Biosciences
|
◎ Target | Jeffrey Hung not yet tracked | Equal Weight | $182.00→ $183.00+0.5% |
|
Sep 12
00:09 UTC
|
MGM
MGM Resorts International
|
◎ Target | Robin Farley not yet tracked | Neutral | $50.00→ $46.00-8.0% |
|
Sep 12
00:09 UTC
|
MCFT
Mastercraft Boat
|
◎ Target | Craig Kennison ★★★★☆ #407 | Neutral | $30.00→ $26.00-13.3% |
|
Sep 12
00:09 UTC
|
MCD
McDonald's
|
◎ Target | Andrew M. Charles not yet tracked | Hold | $300.00→ $282.00-6.0% |
|
Sep 12
00:09 UTC
|
MAS
Masco
|
◎ Target | Sam Reid ★★☆☆☆ #2801 | Overweight | $87.00→ $82.00-5.7% |
|
Sep 12
00:09 UTC
|
LUV
Southwest Airlines
|
◎ Target | Brandon Oglenski ★★☆☆☆ #2678 | Overweight | $65.00→ $58.00-10.8% |
|
Sep 12
00:09 UTC
|
LOVE
Lovesac
|
◎ Target | Michael Baker ★★★☆☆ #1028 | Buy | $20.00→ $18.00-10.0% |
|
Sep 12
00:09 UTC
|
LH
Labcorp
|
◎ Target | Kevin Caliendo ★★★☆☆ #1079 | Buy | $361.00→ $380.00+5.3% |
|
Sep 12
00:09 UTC
|
LH
Labcorp
|
◎ Target | Jack Meehan ★★☆☆☆ #2853 | Equal Weight | $320.00→ $330.00+3.1% |
|
Sep 12
00:09 UTC
|
LEN
Lennar
|
◎ Target | Sam Reid ★★☆☆☆ #2801 | Equal Weight | $85.00→ $80.00-5.9% |
|
Sep 12
00:09 UTC
|
LEGN
Legend Biotech
|
◎ Target | Etzer Darout ★★★☆☆ #2209 | Overweight | $78.00→ $74.00-5.1% |
|
Sep 12
00:09 UTC
|
KMB
Kimberly-Clark
|
◎ Target | Michael Lavery ★★★☆☆ #2048 | Overweight | $121.00→ $118.00-2.5% |
|
Sep 12
00:09 UTC
|
KBH
KB Home
|
◎ Target | Sam Reid ★★☆☆☆ #2801 | Underweight | $52.00→ $50.00-3.8% |
|
Sep 12
00:09 UTC
|
JMKE
Jersey Mike's
|
◎ Target | Ivan Feinseth ★★★☆☆ #1380 | Buy | $29.00→ $30.00+3.4% |
|
Sep 12
00:09 UTC
|
JMKE
Jersey Mike's
|
◎ Target | Gregory Francfort ★★★★☆ #824 | Buy | $28.00→ $29.00+3.6% |
|
Sep 12
00:09 UTC
|
JEF
Jefferies Financial Group
|
◎ Target | Brennan Hawken ★★★☆☆ #1348 | Market Perform | $60.00→ $57.00-5.0% |
|
Sep 12
00:09 UTC
|
JEF
Jefferies Financial Group
|
◎ Target | Michael Brown ★★★☆☆ #1587 | Neutral | $65.00→ $61.00-6.2% |
|
Sep 12
00:09 UTC
|
JBLU
JetBlue Airways
|
◎ Target | Brandon Oglenski ★★☆☆☆ #2678 | Equal Weight | $7.00→ $5.00-28.6% |
|
Sep 12
00:09 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Ashwani Verma ★★★★☆ #732 | Buy | $315.00→ $337.00+7.0% |
|
Sep 12
00:09 UTC
|
INSP
Inspire Medical Systems
|
◎ Target | Jonathan Block ★★★☆☆ #1724 | Buy | $75.00→ $80.00+6.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.